Fortrea Holdings

FTRE

Market cap $880M

DURHAM, N.C., Oct. 15, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced that it will release its third quarter 2025 financial results before the market opens on Wednesday, November 5, 2025. Fortrea will host a conference call at 8:00 am ET that day to review its financial results and conduct a question-and-answer session.

Amid U.S.-China tensions and the U.S. government shutdown, five high-earnings-yield value stocks stand out for long-term investors.

DURHAM, N.C., Sept. 22, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced the appointment of William Sharbaugh to the Company's Board of Directors. Mr. Sharbaugh brings extensive healthcare experience in finance, operations, manufacturing, and quality to the position, having served in executive and board roles during his more than three decades in the pharmaceutical industry.

DURHAM, N.C., Sept. 12, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization, today announced the granting of an inducement award of restricted stock units (“RSUs”) on September 12, 2025, to one newly hired employee. The award consisted of 75,000 RSUs that vest in three equal annual installments starting September 12, 2026, subject to the employee's continuous employment through the applicable vesting date. The RSUs are subject to the terms and conditions of the Company's Amended and Restated 2025 Inducement Award Plan and the award agreements covering the grants. These awards follow Nasdaq Listing Rule 5635(c)(4) and are intended as an inducement material to the individual becoming a new employee of the Company.

NEW YORK , Sept. 9, 2025 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Fortrea Holdings, Inc. (NASDAQ: FTRE)  breached their fiduciary duties to shareholders.

SAN DIEGO , Aug. 25, 2025 /PRNewswire/ -- Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in NASDAQ: FTRE shares over alleged securities laws violations by Fortrea Holdings Inc. Investors who purchased shares of Fortrea Holdings Inc. prior to July 2023 and continue to hold any of those NASDAQ: FTRE shares also have certain options and contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. On May 23, 2025, a NASDAQ: FTRE investor filed a lawsuit against Fortrea Holdings Inc. The plaintiff alleged that the defendants made false and/or misleading statements and/or failed to disclose that Fortrea overestimated the amount of revenue the Pre-Spin Projects were likely to contribute to the Company's 2025 earnings, that Fortrea overstated the cost savings it would likely achieve by exiting the TSAs, that as a result, the Company's previously announced EBITDA targets for 2025 were inflated, that accordingly, the viability of the Company's post-Spin-Off business model, as well as its business and/or financial prospects, were overstated, and that as a result, the Company's public statements were materially false and misleading at all relevant times.

Fortrea Holdings Inc. (NASDAQ:FTRE ) Q2 2025 Earnings Conference Call August 6, 2025 8:00 AM ET Company Participants Anshul Thakral - Corporate Participant Hima B. Inguva - Head of Investor Relations & Corporate Development Jill McConnell - Chief Financial Officer Peter M.

Fortrea (FTRE) Q2 Revenue Jumps 7%

Fortrea Holdings Inc. (FTRE) came out with quarterly earnings of $0.19 per share, beating the Zacks Consensus Estimate of $0.06 per share. This compares to a loss of $0.03 per share a year ago.

For the three months ended June 30, 2025, from continuing operations: Revenues of $710.3 million GAAP net loss of $(374.9) million, inclusive of a non-cash goodwill impairment charge Adjusted EBITDA of $54.9 million GAAP and adjusted net (loss) income per diluted share of $(4.14) and $0.19, respectively Book-to-bill ratio of 0.79x, resulting in 1.10x book-to-bill for the trailing 12 months Cost saving initiatives remain on track Raising 2025 revenue guidance to a range of $2,600 million to $2,700 million; affirming 2025 adjusted EBITDA guidance DURHAM, N.C., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today reported financial results for the second quarter ended June 30, 2025.